Specializing in orthopedic oncology and metabolic bone diseases, Howard Rosenthal, MD, and his staff will open a Sarcoma Center, a center for bone and other complex cancers, in July, at the hospital’s Indian Creek Campus, located at I-435 and Nall.
Dr. Rosenthal brings a well-known reputation for successfully treating sarcoma and other bone and soft tissue tumors, benign and malignant, for patients in a six-state region throughout the Midwest.
The center will use state of the art technology and innovative treatment options to enhance patient survival and functional outcomes.
“As a nationally recognized surgeon, Dr. Rosenthal brings a wealth of knowledge and experience to the organization. In addition to treating sarcoma and other bone and soft tissue tumors, the Sarcoma Center will offer a full array of clinical trials under the National Cancer Institute research designation.” said Bruce Toby, MD, chair of Orthopedic Surgery at The University of Kansas Hospital.
Dr. Toby noted Kim Templeton, MD, orthopedic surgeon and Josh Mammen, MD, surgical oncologist also provide treatment for bone cancers as part of the cancer center.
Dr. Rosenthal is a renowned and respected colleague in the metropolitan area. He completed his internship in General Surgery and residency in Orthopedic Surgery at the University of Kansas Medical Center.
He also completed a fellowship in Orthopedic Oncology and Metabolic Bone Diseases at Memorial Sloan-Kettering Cancer Center. Over the past 17 years he has served as Medical Director of the Mid America Sarcoma Institute based in the Kansas City metropolitan area.
Dr. Rosenthal will become a faculty member of the University Of Kansas School of Medicine and operate his clinic under The University of Kansas Cancer Center.
